Infection with hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Melon, Alexandra ^a   Wang, Arthur ^a   Phan, Van ^a   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 4; NITROBENZENE DERIVATIVE; SULFONIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; BENZENESULFONIC ACID DERIVATIVE; CYTOKINE; DINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HISTOPATHOLOGY; HYMENOLEPIASIS; HYMENOLEPIS DIMINUTA; MALE; MOUSE; NONHUMAN; SPLEEN CELL; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CYTOCHEMISTRY; DISEASE MODEL; DRUG ANTAGONISM; EOSINOPHIL; METABOLISM; PARASITOLOGY; SPLEEN;

HYMENOLEPIS DIMINUTA; MUS; VERMES;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZENESULFONATES; COLITIS; COLLAGEN; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EOSINOPHILS; HISTOCYTOCHEMISTRY; HYMENOLEPIASIS; HYMENOLEPIS DIMINUTA; MALE; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 77949316370     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/384523     Document Type: Article

References (26)

1. J.-F. Bach, "The effect of infections on susceptibility to autoimmune and allergic diseases," The New England Journal of Medicine, vol. 347, no. 12, pp. 911-920, 2002.
2. M. Yazdanbakhsh, P. G. Kremsner, and R. van Ree, "Allergy, parasites and the hygiene hypothesis," Science, vol. 296, pp. 490-494, 2002.
3. D. E. Elliott, J. F. Urban Jr., C. K. Argo, and J. V. Weinstock, "Does the failure to acquire helminthic parasites predispose to Crohn's disease?" The FASEB Journal, vol. 14, no. 12, pp. 1848-1855, 2000.
4. D. E. Elliott, R. W. Summers, and J. V. Weinstock, "Helminths as governors of immune-mediated inflammation," International Journal for Parasitology, vol. 37, no. 5, pp. 457-464, 2007. (Pubitemid 46399709)
5. R. M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M. D. Taylor, and J. E. Allen, "Helminth parasites-masters of regulation," Immunological Reviews, vol. 201, pp. 89-116, 2004.
6. M. G. Nair, K. J. Guild, and D. Artis, "Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy," The Journal of Immunology, vol. 177, no. 3, pp. 1393-1399, 2006. (Pubitemid 44092469)
7. M. M. Hunter, A. Wang, C. L. Hirota, and D. M. McKay, "Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis," The Journal of Immunology, vol. 174, no. 11, pp. 7368-7375, 2005. (Pubitemid 40705707)
8. D. M. McKay, "The therapeutic helminth?" Trendsin Parasitology, vol. 25, no. 3, pp. 109-114, 2009.
9. H. J. van Kruiningen and A. B. West, "Iatrogenic Trichuris suis infection," Archives of Pathology and Laboratory Medicine, vol. 131, no. 2, p. 180, 2007.
10. R. W. Summers, D. E. Elliot, J. F. Urban Jr., R. Thompson, and J. V. Weinstock, "Trichuris suis therapy in Crohn's disease," Gut, vol. 54, no. 1, pp. 87-90, 2005. (Pubitemid 40007223)
11. K. Mortimer, A. Brown, J. Feary, et al., "Dose-ranging study for trials of therapeutic infection with Necator americanus in humans," American Journal of Tropical Medicine and Hygiene, vol. 75, no. 5, pp. 914-920, 2006. (Pubitemid 351627540)
12. R. Persaud, A. Wang, C. Reardon, and D. M. McKay, "Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host," International Journal for Parasitology, vol. 37, no. 3-4, pp. 393-403, 2007. (Pubitemid 46215582)
13. A. Lamrani, M. Tulliez, L. Chauvelot-Moachon, et al., "Effects of octreotide treatment on early TNF-α production and localization in experimental chronic colitis," Alimentary Pharmacology and Therapeutics, vol. 13, no. 5, pp. 583-594, 1999. (Pubitemid 29219023)
14. J. Stein, J. Ries, and K. E. Barrett, "Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells," American Journal of Physiology, vol. 274, no. 1, pp. G203-G209, 1998.
15. A. Sood, V. Midha, N. Sood, and G. Awasthi, "A prospective, open-label trial assessing dexamethasone pulse therapy in moderate to severe ulcerative colitis," Journal of Clinical Gastroenterology, vol. 35, no. 4, pp. 328-331, 2002.
16. M. M. Hunter, A. Wang, and D. M. McKay, "Helminth infection enhances disease in a murine TH2 model of colitis," Gastroenterology, vol. 132, no. 4, pp. 1320-1330, 2007. (Pubitemid 46627574)
17. A. Wang and D. M. McKay, "Immune modulation by a high molecular weight fraction from the rat tapeworm Hymenolepis diminuta," Parasitology, vol. 130, no. 5, pp. 575-585, 2005. (Pubitemid 40685772)
18. B. E. Sands, "Inflammatory bowel disease: past, present, and future," Journal of Gastroenterology, vol. 42, no. 1, pp. 16-25, 2007. (Pubitemid 46351421)
19. M. R. Ehrenstein, J. G. Evans, A. Singh, et al., "Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy," Journal of Experimental Medicine, vol. 200, no. 3, pp. 277-285, 2004. (Pubitemid 39031247)
20. M. Desowitz, "Harmonius parasites," in New Guinea Tapeworms and Jewish Grandmothers, pp. 179-205, Pickwick, London, UK, 1981.
21. J. V. Weinstock and D. E. Elliott, "Helminths and the IBD hygiene hypothesis," Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 128-133, 2009.
22. M. N. Ince, D. E. Elliott, T. Setiawan, et al., "Role of T cell TGF-β signaling in intestinal cytokine responses and helminthic immune modulation," European Journal of Immunology, vol. 39, no. 7, pp. 1870-1878, 2009.
23. C. Daniel, N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein, "Immune modulatory treatment of trinitrobenzene sul-fonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile," Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 1, pp. 23-33, 2008. (Pubitemid 350294165)
24. L. Cannarile, S. Cuzzocrea, L. Santucci, et al., "Glucocorticoid- induced leucine zipper is protective in Th1-mediated models of colitis," Gastroenterology, vol. 136, no. 2, pp. 530-541, 2009.
25. O. Atug, H. Hamzaoglu, V. Tahan, et al., "Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis," Digestive Diseases and Sciences, vol. 53, no. 2, pp. 481-485, 2008. (Pubitemid 351170041)
26. M. E. van Meeteren, M. A. C. Meijssen, and F. J. Zijlstra, "The effect of dexamethasone treatment on murine colitis," Scandinavian Journal of Gastroenterology, vol. 35, no. 5, pp. 517-521, 2000. (Pubitemid 30354092)